Trials / Completed
CompletedNCT01030705
Common Sensing and Right Ventricular Automatic Capture (COGNATE)
Common Sensing and Right Ventricular Automatic Capture
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will collect data on features for future pacemakers via an external non-implantable system.
Detailed description
COGNATE is an acute, confirmatory prospective, multi-center study designed to gather data on Brady and CRT-P indicated patients, with no restrictions on the type/brand of leads. This study will enroll up to 80 patients in up to 12 centers. Total duration of the study is expected to be 9 months.
Conditions
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2009-12-11
- Last updated
- 2011-09-29
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01030705. Inclusion in this directory is not an endorsement.